1. 上海中医药大学附属岳阳中西医结合医院肿瘤一科,上海,200437
2. 上海中医药大学附属龙华医院肿瘤科,上海,200032
3. 上海市中医药研究院中医肿瘤研究所,上海,200032
扫 描 看 全 文
周迪, 董昌盛, 许玲, 等. 龙藤通络酒剂外用联合三阶梯止痛药物治疗癌性疼痛的临床观察[J]. 上海中医药杂志, 2020,54(11):38-42.
ZHOU Di, DONG Changsheng, XU Ling, et al. Clinical observation on external application of Longteng Tongluo Tincture combined with three-step analgesic ladder in treating cancer pain[J]. Shanghai Journal of Traditional Chinese Medicine, 2020,54(11):38-42.
周迪, 董昌盛, 许玲, 等. 龙藤通络酒剂外用联合三阶梯止痛药物治疗癌性疼痛的临床观察[J]. 上海中医药杂志, 2020,54(11):38-42. DOI: 10.16305/j.1007-1334.2020.2002114.
ZHOU Di, DONG Changsheng, XU Ling, et al. Clinical observation on external application of Longteng Tongluo Tincture combined with three-step analgesic ladder in treating cancer pain[J]. Shanghai Journal of Traditional Chinese Medicine, 2020,54(11):38-42. DOI: 10.16305/j.1007-1334.2020.2002114.
目的:评价龙藤通络酒剂外用联合三阶梯止痛药物治疗癌性疼痛的疗效及安全性。 方法:将100例癌性疼痛患者随机分为治疗组和对照组,每组50例。两组均采用三阶梯止痛药物止痛治疗,治疗组在此基础上联合龙藤通络酒剂外用。两组疗程均为8 d,观察疼痛数字评价量表(NRS)评分的变化情况,并据此评价疼痛疗效;观察等效吗啡消耗量、爆发痛次数及止痛起效时间,同时进行安全性评价。 结果:①治疗组疼痛缓解总有效率为65.85%,显效率为31.70%,均高于对照组的44.19%和18.60%;在整体疼痛疗效方面,治疗组优于对照组(P<0.05)。②两组治疗后NRS评分均较治疗前下降(P<0.05),且治疗组NRS评分的下降幅度大于对照组(P<0.05)。进一步分层分析,治疗前后组内比较,两组各疼痛程度患者NRS评分均降低(P<0.05);组间治疗后比较,在中度疼痛患者中,治疗组NRS评分差值大于对照组(P<0.05)。③治疗组首日吗啡消耗量、日均等效吗啡用量比较,差异无统计学意义(P>0.05);进一步分层比较,治疗组中度疼痛患者的日均等效吗啡用量少于对照组相同疼痛程度患者(P<0.05)。④两组爆发痛次数、爆发痛平均止痛起效时间及不良反应发生率比较,差异无统计学意义(P>0.05)。 结论:在癌性疼痛的治疗中,龙藤通络酒剂与阿片类止痛药物合用具有协同、增效的作用,尤其是对于中度癌性疼痛患者,能减少阿片类药物的日均消耗量,且安全性好,值得进一步推广。
Objective:To evaluate the efficacy and safety of Longteng Tongluo Tincture combined with three-step analgesic ladder in the treatment of cancer pain. MethodsA total of 100 patients with cancer pain were randomly divided into treatment group and control group, with 50 cases in each group. Both groups were treated based on three-step analgesic ladder. The treatment group was also administered Longteng Tongluo Tincture for external use. The course of treatment in both groups was 8 days, and Numeric Rating Scale (NRS) score changes were observed to quantify pain and evaluate pain-relieving effect accordingly. The morphine equivalent daily consumption, the frequency of pain outbreaks and the onset time of analgesia were observed, and the safety was evaluated simultaneously. Results:①The total effective rate of pain relief in the treatment group was 65.85%, and the obvious effective rate was 31.70%, which were higher than 44.19% and 18.60% in the control group. In terms of overall pain-relieving effect, the treatment group performed better than the control group (P<0.05). ②The NRS scores of the two groups decreased after treatment compared with those before treatment (P<0.05), and the decrease range of NRS scores in the treatment group was greater than that in the control group (P<0.05). Further stratified comparison showed that NRS scores of patients with various pain degrees in both groups decreased after treatment (P<0.05). Besides, among patients with moderate pain, the difference of NRS scores compared before and after treatment in the treatment group was greater than that in the control group (P<0.05). ③There was no significant difference in morphine consumption on the first day and average morphine equivalent daily consumption between the two groups (P>0.05). Further stratification comparison showed that the average morphine equivalent daily consumption of patients with moderate pain in the treatment group was less than that in the control group (P<0.05). ④There was no significant difference between the two groups in the frequency of pain outbreaks, the mean analgesic onset time and the incidence of adverse reactions (P>0.05). Conclusion:In the treatment of cancer pain, Longteng Tongluo Tincture and opioid analgesics have synergistic effects. Thus, it is worthy of further promotion as it can reduce the daily average consumption of opioids with good safety, especially for patients with moderate cancer pain.
癌性疼痛三阶梯止痛龙藤通络方酒剂中医外治法
cancer painthree-step analgesic ladderLongteng Tongluo Formulatinctureexternal treatment of traditional Chinese medicine
0
浏览量
257
下载量
0
CSCD
15
CNKI被引量
关联资源
相关文章
相关作者
相关机构